Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
37 hedge funds and large institutions have $33.8M invested in Zomedica Corp. in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.
2,500% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 1
2,005% more capital invested
Capital invested by funds: $1.61M → $33.8M (+$32.2M)
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
208% more funds holding
Funds holding: 12 → 37 (+25)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$23.9M |
| 2 |
BlackRock
New York
|
+$3.17M |
| 3 |
State Street
Boston,
Massachusetts
|
+$600K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$276K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$205K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$895K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$11.7K |
ZOM Hedge Fund Activity: Q2 2018 in Review
37 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2018, worth a combined $33.8M — up 2,005% from $1.61M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ZOM positions and 1 closed out — a net gain of 25 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Cambridge Investment Research Advisors, adding an estimated $23.9M. The largest seller was Millennium Management, exiting entirely with an estimated $895K sold.
- 37 institutional investors held Zomedica Corp. (ZOM) as of Q2 2018, up from 12 in Q1 2018.
- Funds reported $33.8M of Zomedica Corp. stock for Q2 2018, up 2,005% quarter-over-quarter.
- 26 funds opened new Zomedica Corp. positions in Q2 2018 and 1 closed out, a net change of +25 holders.
- The largest Zomedica Corp. buyer in Q2 2018 was Cambridge Investment Research Advisors, an estimated $23.9M added.
- The largest Zomedica Corp. seller in Q2 2018 was Millennium Management, an estimated $895K sold.
Based on aggregated 13F filings for Q2 2018.